For pharma marketers, 2012 needs to be the year when they figure out how to stimulate positive conversation about their brand, both online and offline. The recent FDA Draft Guidelines didn’t provide much to go on, but at least it’s a start - and perhaps can offer some level of ammunition for marketers to educate their MLR teams on where the lines really are.  

I can hear pharma marketers now, ringing their hands in frustration, expressing annoyance about their perceived inability to engage with consumers in a more authentic and compelling fashion. Some might even be wishing they could run an ad this weekend during the Super Bowl and all of their problems would be solved.  

Think again. And take note of two really important findings that came out today.